{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T23:34:02Z","timestamp":1773099242388,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:00:00Z","timestamp":1721174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:00:00Z","timestamp":1721174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Chongqing Natural Science Foundation Project","award":["cstc2020jcyj-msxmX1085"],"award-info":[{"award-number":["cstc2020jcyj-msxmX1085"]}]},{"name":"Chongqing Natural Science Foundation Project","award":["cstc2020jcyj-msxmX1085"],"award-info":[{"award-number":["cstc2020jcyj-msxmX1085"]}]},{"name":"Chongqing Science and health joint medical research Project","award":["2020FYYX129"],"award-info":[{"award-number":["2020FYYX129"]}]},{"name":"Chongqing University Central Hospital Scientific Research Foundation","award":["2021KYQD1113"],"award-info":[{"award-number":["2021KYQD1113"]}]},{"name":"Chongqing Science and Health United Traditional Chinese Medicine Project","award":["2019ZY023436"],"award-info":[{"award-number":["2019ZY023436"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-024-04156-9","type":"journal-article","created":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T11:02:16Z","timestamp":1721214136000},"page":"187-196","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and safety of dual renin\u2013angiotensin system (RAS) blockade for non-elderly diabetic kidney disease patients with preserved eGFR"],"prefix":"10.1007","volume":"57","author":[{"given":"Mei","family":"Mei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sha","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haili","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaolin","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyin","family":"Chai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingbing","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,17]]},"reference":[{"issue":"2","key":"4156_CR1","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.kint.2017.01.030","volume":"92","author":"CP Wen","year":"2017","unstructured":"Wen CP, Chang CH, Tsai MK, Lee JH, Lu PJ, Tsai SP et al (2017) Diabetes with early kidney involvement may shorten life expectancy by 16 years. Kidney Int 92(2):388\u2013396","journal-title":"Kidney Int"},{"issue":"4","key":"4156_CR2","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1159\/000506634","volume":"6","author":"Y Chen","year":"2020","unstructured":"Chen Y, Lee K, Ni Z, He JC (2020) Diabetic kidney disease: challenges, advances, and opportunities. Kidney Dis (Basel, Switz) 6(4):215\u2013225","journal-title":"Kidney Dis (Basel, Switz)"},{"issue":"5","key":"4156_CR3","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.drudis.2020.01.008","volume":"25","author":"N Raval","year":"2020","unstructured":"Raval N, Kumawat A, Kalyane D, Kalia K, Tekade RK (2020) Understanding molecular upsets in diabetic nephropathy to identify novel targets and treatment opportunities. Drug Discov Today 25(5):862\u2013878","journal-title":"Drug Discov Today"},{"issue":"24","key":"4156_CR4","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","volume":"380","author":"V Perkovic","year":"2019","unstructured":"Perkovic V, Jardine MJ, Neal B, Bompoint S, Heerspink HJL, Charytan DM et al (2019) Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. N Engl J Med 380(24):2295\u20132306","journal-title":"N Engl J Med"},{"key":"4156_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232112823","author":"A Vergara","year":"2022","unstructured":"Vergara A, Jacobs-Cacha C, Llorens-Cebria C, Ortiz A, Martinez-Diaz I, Martos N et al (2022) Enhanced cardiorenal protective effects of combining SGLT2 inhibition, endothelin receptor antagonism and RAS blockade in type 2 diabetic mice. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms232112823","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4156_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1159\/000513119","volume":"145","author":"M Mei","year":"2021","unstructured":"Mei M, Zhou Z, Zhang Q, Chen Y, Zhao H, Shen B (2021) Dual blockade of the renin\u2013angiotensin system: a strategy that should be reconsidered in cardiorenal diseases? Nephron 145(2):99\u2013106","journal-title":"Nephron"},{"issue":"3","key":"4156_CR7","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1046\/j.1523-1755.2003.00832.x","volume":"63","author":"R Campbell","year":"2003","unstructured":"Campbell R, Sangalli F, Perticucci E, Aros C, Viscarra C, Perna A et al (2003) Effects of combined ACE inhibitor and angiotensin II antagonist treatment in human chronic nephropathies. Kidney Int 63(3):1094\u20131103","journal-title":"Kidney Int"},{"issue":"15","key":"4156_CR8","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","volume":"358","author":"S Yusuf","year":"2008","unstructured":"Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H et al (2008) Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 358(15):1547\u20131559","journal-title":"N Engl J Med"},{"issue":"23","key":"4156_CR9","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1056\/NEJMoa1208799","volume":"367","author":"HH Parving","year":"2012","unstructured":"Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD et al (2012) Cardiorenal end points in a trial of aliskiren for type 2 diabetes. N Engl J Med 367(23):2204\u20132213","journal-title":"N Engl J Med"},{"issue":"20","key":"4156_CR10","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1056\/NEJMoa1303154","volume":"369","author":"LF Fried","year":"2013","unstructured":"Fried LF, Emanuele N, Zhang JH, Brophy M, Conner TA, Duckworth W et al (2013) Combined angiotensin inhibition for the treatment of diabetic nephropathy. N Engl J Med 369(20):1892\u20131903","journal-title":"N Engl J Med"},{"issue":"11","key":"4156_CR11","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.2215\/CJN.03470316","volume":"11","author":"PM Palevsky","year":"2016","unstructured":"Palevsky PM, Zhang JH, Seliger SL, Emanuele N, Fried LF (2016) Incidence, severity, and outcomes of AKI associated with dual renin\u2013angiotensin system blockade. Clin J Am Soc Nephrol CJASN 11(11):1944\u20131953","journal-title":"Clin J Am Soc Nephrol CJASN"},{"issue":"9502","key":"4156_CR12","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1016\/S0140-6736(05)67814-2","volume":"366","author":"JP Casas","year":"2005","unstructured":"Casas JP, Chua W, Loukogeorgakis S, Vallance P, Smeeth L, Hingorani AD et al (2005) Effect of inhibitors of the renin\u2013angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis. Lancet (Lond, England) 366(9502):2026\u20132033","journal-title":"Lancet (Lond, England)"},{"issue":"6","key":"4156_CR13","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1681\/ASN.2007090970","volume":"19","author":"P Ruggenenti","year":"2008","unstructured":"Ruggenenti P, Perticucci E, Cravedi P, Gambara V, Costantini M, Sharma SK et al (2008) Role of remission clinics in the longitudinal treatment of CKD. J Am Soc Nephrol 19(6):1213\u20131224","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"4156_CR14","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1152\/physrev.00023.2016","volume":"98","author":"RAS Santos","year":"2018","unstructured":"Santos RAS, Sampaio WO, Alzamora AC, Motta-Santos D, Alenina N, Bader M et al (2018) The ACE2\/angiotensin-(1\u20137)\/MAS axis of the renin\u2013angiotensin system: focus on angiotensin-(1\u20137). Physiol Rev 98(1):505\u2013553","journal-title":"Physiol Rev"},{"issue":"946","key":"4156_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175623","volume":"5","author":"V Tiwari","year":"2023","unstructured":"Tiwari V, Singh J, Tiwari P, Chaturvedi S, Gupta S, Mishra A et al (2023) ACE2\/ANG-(1\u20137)\/Mas receptor axis activation prevents inflammation and improves cognitive functions in streptozotocin induced rat model of Alzheimer\u2019s disease-like phenotypes. Eur J Pharmacol 5(946):175623","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"4156_CR16","doi-asserted-by":"publisher","first-page":"R1461","DOI":"10.1152\/ajpregu.00014.2007","volume":"293","author":"HM Siragy","year":"2007","unstructured":"Siragy HM, Inagami T, Carey RM (2007) NO and cGMP mediate angiotensin AT2 receptor-induced renal renin inhibition in young rats. Am J Physiol Regul Integr Comp Physiol 293(4):R1461\u2013R1467","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"11","key":"4156_CR17","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1161\/CIRCULATIONAHA.115.018622","volume":"133","author":"SA Hubers","year":"2016","unstructured":"Hubers SA, Brown NJ (2016) Combined angiotensin receptor antagonism and neprilysin inhibition. Circulation 133(11):1115\u20131124","journal-title":"Circulation"},{"issue":"Suppl 2","key":"4156_CR18","doi-asserted-by":"publisher","first-page":"S163","DOI":"10.1093\/geront\/gnw037","volume":"56","author":"JR Beard","year":"2016","unstructured":"Beard JR, Officer AM, Cassels AK (2016) The world report on ageing and health. Gerontologist 56(Suppl 2):S163\u2013S166","journal-title":"Gerontologist"},{"issue":"4s","key":"4156_CR19","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","volume":"100","author":"BH Rovin","year":"2021","unstructured":"Rovin BH, Adler SG, Barratt J, Bridoux F, Burdge KA (2021) KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int 100(4s):S1-s276","journal-title":"Kidney Int"},{"issue":"2","key":"4156_CR20","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2215\/CJN.07460713","volume":"9","author":"PN Van Buren","year":"2014","unstructured":"Van Buren PN, Adams-Huet B, Nguyen M, Molina C, Toto RD (2014) Potassium handling with dual renin\u2013angiotensin system inhibition in diabetic nephropathy. Clin J Am Soc Nephrol CJASN 9(2):295\u2013301","journal-title":"Clin J Am Soc Nephrol CJASN"},{"issue":"12","key":"4156_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-012690","volume":"6","author":"KE Mansfield","year":"2016","unstructured":"Mansfield KE, Nitsch D, Smeeth L, Bhaskaran K, Tomlinson LA (2016) Prescription of renin\u2013angiotensin system blockers and risk of acute kidney injury: a population-based cohort study. BMJ Open 6(12):e012690","journal-title":"BMJ Open"},{"issue":"12","key":"4156_CR22","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1681\/ASN.2012040390","volume":"23","author":"P Ruggenenti","year":"2012","unstructured":"Ruggenenti P, Cravedi P, Remuzzi G (2012) Mechanisms and treatment of CKD. J Am Soc Nephrol 23(12):1917\u20131928","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"4156_CR23","first-page":"542","volume":"38","author":"RM Zhang","year":"2023","unstructured":"Zhang RM, Persson F, McGill JB, Rossing P (2023) Clinical implications and guidelines for CKD in type 2 diabetes. Nephrol Dial Transplant Official Publ Eur Dial Transpl Assoc Eur Ren Assoc 38(3):542\u2013550","journal-title":"Nephrol Dial Transplant Official Publ Eur Dial Transpl Assoc Eur Ren Assoc"},{"issue":"5","key":"4156_CR24","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1111\/dom.13639","volume":"21","author":"P Ruggenenti","year":"2019","unstructured":"Ruggenenti P, Trillini M, Barlovic DP, Cortinovis M, Pisani A, Parvanova A et al (2019) Effects of valsartan, benazepril and their combination in overt nephropathy of type 2 diabetes: a prospective, randomized, controlled trial. Diabetes Obes Metab 21(5):1177\u20131190","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"4156_CR25","first-page":"683","volume":"21","author":"JH Song","year":"2006","unstructured":"Song JH, Cha SH, Lee HJ, Lee SW, Park GH, Lee SW et al (2006) Effect of low-dose dual blockade of renin\u2013angiotensin system on urinary TGF-beta in type 2 diabetic patients with advanced kidney disease. Nephrol Dialysis transpl Official Publ Eur Dial Transpl Assoc Eur Ren Assoc 21(3):683\u2013689","journal-title":"Nephrol Dialysis transpl Official Publ Eur Dial Transpl Assoc Eur Ren Assoc"},{"issue":"10","key":"4156_CR26","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1111\/j.1742-1241.2012.02970.x","volume":"66","author":"J Cheng","year":"2012","unstructured":"Cheng J, Zhang X, Tian J, Li Q, Chen J (2012) Combination therapy an ACE inhibitor and an angiotensin receptor blocker for IgA nephropathy: a meta-analysis. Int J Clin Pract 66(10):917\u2013923","journal-title":"Int J Clin Pract"},{"issue":"9982","key":"4156_CR27","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/S0140-6736(14)62459-4","volume":"385","author":"SC Palmer","year":"2015","unstructured":"Palmer SC, Mavridis D, Navarese E, Craig JC, Tonelli M, Salanti G et al (2015) Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis. Lancet (Lond, Engl) 385(9982):2047\u20132056","journal-title":"Lancet (Lond, Engl)"},{"issue":"9982","key":"4156_CR28","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/S0140-6736(15)60132-5","volume":"385","author":"TH Jafar","year":"2015","unstructured":"Jafar TH, Assam PN (2015) Dual RAAS blockade for kidney failure: hope for the future. Lancet (Lond, Engl) 385(9982):2018\u20132020","journal-title":"Lancet (Lond, Engl)"},{"issue":"4","key":"4156_CR29","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1177\/2042098615589905","volume":"6","author":"R Esteras","year":"2015","unstructured":"Esteras R, Perez-Gomez MV, Rodriguez-Osorio L, Ortiz A, Fernandez-Fernandez B (2015) Combination use of medicines from two classes of renin\u2013angiotensin system blocking agents: risk of hyperkalemia, hypotension, and impaired renal function. Ther Adv Drug Saf 6(4):166\u2013176","journal-title":"Ther Adv Drug Saf"},{"key":"4156_CR30","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.2147\/CIA.S159715","volume":"13","author":"M D\u00f6rks","year":"2018","unstructured":"D\u00f6rks M, Herget-Rosenthal S, Hoffmann F, Jobski K (2018) Combined use of drugs inhibiting the renin\u2013angiotensin system: prescribing patterns and risk of acute kidney injury in German nursing home residents. Clin Interv Aging 13:1035\u20131042","journal-title":"Clin Interv Aging"},{"issue":"4","key":"4156_CR31","doi-asserted-by":"publisher","first-page":"147032031988265","DOI":"10.1177\/1470320319882656","volume":"20","author":"AR Silva","year":"2019","unstructured":"Silva AR, Martini AG, Canto GL, Guerra E, Neves FAR (2019) Effects of dual blockade in heart failure and renal dysfunction: systematic review and meta-analysis. J Renin Angiotensin Aldosterone Syst JRAAS 20(4):1470320319882656","journal-title":"J Renin Angiotensin Aldosterone Syst JRAAS"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-024-04156-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-024-04156-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-024-04156-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T03:07:07Z","timestamp":1735873627000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-024-04156-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,17]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["4156"],"URL":"https:\/\/doi.org\/10.1007\/s11255-024-04156-9","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,17]]},"assertion":[{"value":"13 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Our patients gave their written informed consent for inclusion and the study protocol was approved by the ethical committee (KY201994).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}